T1	Participants 32 56	low-risk trabeculectomy.
T2	Participants 179 267	population of low-risk glaucoma patients in whom antimetabolites might not be indicated.
T3	Participants 310 459	65 eyes was designed, with 31 eyes receiving 750 rads of intraoperative beta radiation (group 1), and 34 eyes receiving no supplementation (group 2).
T4	Participants 824 841	low-risk patients
